Highlights Cizzle Biotechnology Holdings Plc

Equities

PSL

GB00BNG2VN02

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 10:05:09 06/02/2026 pm IST			5-day change	1st Jan Change
1.550 ^GBX	0.00%		+10.71%	-

04/02	Cizzle secures Canadian patent for lung cancer test format	AN
04/02	Cizzle Biotechnology Lung Cancer Test Secures Patent in Canada	MT

Highlights

04/02	Cizzle Biotechnology Lung Cancer Test Secures Patent in Canada	MT
04/02	Cizzle Biotechnology Holdings plc Announces Patent Applications That Claim Protection for Methods That Measure the Ciz1b Lung Cancer Biomarker	CI
30/25/30	EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx	AN
30/25/30	Cizzle Biotechnology Announces Update on Clinical Laboratory Partnerships in Usa	CI
30/25/30	Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Half Year Ended June 30, 2025	CI
19/25/19	EARNINGS AND TRADING: Capital Metals loss widens; Aptamer's contract	AN
18/25/18	Cizzle Biotechnology Advances US Expansion via Commercialization Deal	MT
18/25/18	Cizzle Biotechnology Holdings plc Announces Commercial Progress in USD Advance Royalty Schedule Revised for Early Payment	CI
21/25/21	GetsBusy backs sales outlook; Cizzle raises funds	AN
30/25/30	Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/25/28	Cizzle Biotechnology Licensing Partner Signs Contract for CIZ1B Lung Cancer Test in Caribbean	MT
28/25/28	Cizzle Biotechnology Holdings plc Announces That Its Licensing Partner Cizzle Bio Inc. Has Executed Its First Contract in the Caribbean	CI
24/25/24	Cizzle Biotechnology Partner Appoints Lab for US Launch of Lung Cancer Test	MT
02/25/02	Cizzle Biotechnology Holdings plc Provides Update on Launch of CIZ1B Biomarker Assay	CI
16/24/16	Cizzle Biotechnology Expands Exclusive Lung Cancer Test Licensing Deal to Caribbean	MT
16/24/16	Cizzle Biotechnology Holdings Plc Announces an Extension to Its Exclusive Licensing and Partnership Agreement with Cizzle Bio Inc	CI
21/24/21	Cizzle Biotechnology Signs Exclusive Licensing Deal for Lung Cancer Test in US	MT
21/24/21	Cizzle Biotechnology Holdings plc Announces North American Licensing Deal to Launch Revolutionary Early Lung Cancer Blood Test in 2025	CI
03/24/03	Cizzle Biotechnology Holdings plc Updated on Licensing and Partnership Agreement	CI
30/24/30	EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens	AN
30/24/30	Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Half Year Ended June 30, 2024	CI
10/24/10	Light Science Technologies wins two new contracts	AN
09/24/09	Cizzle Biotechnology Agrees Lung Cancer Screening Collaboration With US Hospital	MT
09/24/09	Cizzle Biotechnology Holdings plc Announces Collaboration with Moffitt Cancer Center	CI
25/24/25	Cizzle Biotechnology Extends Completion of Agreement with Cizzle Bio	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Cizzle Biotechnology Holdings Plc

Equities

PSL

GB00BNG2VN02

Biotechnology & Medical Research

Highlights

Filters